Sabinsa earns patent in Mexico for Boswellin PS
Sabinsa Corp. expanded its IP portfolio with a patent (MX328842) granted in Mexico for its Boswellia serrata ingredient Boswellin PS.
Photo © Shutterstock.com/jovan vitanovski
Sabinsa Corp. (East Windsor, NJ) expanded its IP portfolio with a patent (MX328842) granted in Mexico for its Boswellia serrata ingredient Boswellin PS. A composition containing boswellic acids and polysaccharides from the Boswellia species, the patent applies to its property of downregulating pro-inflammatory markers.
“Inflammation is an underlying cause of many health conditions throughout the world,” said Muhammed Majeed, PhD, founder and chairman of Sabinsa, in a press release. “By applying modern research to ancient Ayurvedic knowledge Sabinsa has been able to provide natural solutions, including the Boswellin PS ingredient, to this common condition.”
Boswellin PS was also awarded with a patent grant in Australia, Canada, Eurasia, and Taiwan.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”
